These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19501646)

  • 41. Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus.
    Dhaher YY; Greenstein B; de Fougerolles Nunn E; Khamashta M; Hughes GR
    Int J Immunopharmacol; 2000 Mar; 22(3):247-54. PubMed ID: 10685007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
    J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus.
    Kapadia M; Zhao H; Ma D; Sakic B
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):555-564. PubMed ID: 28401431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system.
    Chun S; McEvilly R; Foster JA; Sakic B
    Mol Psychiatry; 2008 Nov; 13(11):1043-53. PubMed ID: 17768421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
    Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
    J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation.
    Du Y; Du L; He Z; Zhou J; Wen C; Zhang Y
    Int Immunopharmacol; 2019 Sep; 74():105677. PubMed ID: 31177018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. All- Trans-Retinoic Acid Augments the Histopathological Outcome of Neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice.
    Theus MH; Sparks JB; Liao X; Ren J; Luo XM
    J Histochem Cytochem; 2017 Feb; 65(2):69-81. PubMed ID: 27856824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
    Liao X; Ren J; Wei CH; Ross AC; Cecere TE; Jortner BS; Ahmed SA; Luo XM
    PLoS One; 2015; 10(3):e0118176. PubMed ID: 25775135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
    Nomura A; Noto D; Murayama G; Chiba A; Miyake S
    Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.
    Alexander JJ; Zwingmann C; Quigg R
    Neurochem Int; 2005 Jul; 47(1-2):143-51. PubMed ID: 15893408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
    Imaruoka K; Oe Y; Fushima T; Sato E; Sekimoto A; Sato H; Sugawara J; Ito S; Takahashi N
    Biochem Biophys Res Commun; 2019 Mar; 510(4):587-593. PubMed ID: 30739788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of flow-mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice.
    Bagi Z; Hamar P; Kardos M; Koller A
    Lupus; 2006; 15(6):326-34. PubMed ID: 16830878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
    Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
    Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus.
    Vogelweid CM; Wright DC; Johnson JC; Hewett JE; Walker SE
    Arthritis Rheum; 1994 Jun; 37(6):889-97. PubMed ID: 8003061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and cloning of a brain autoantigen in neuro-behavioral SLE.
    Moore PM; Vo T; Carlock LR
    J Neuroimmunol; 1998 Mar; 82(2):116-25. PubMed ID: 9585807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteration of DNA methylation levels in MRL lupus mice.
    Mizugaki M; Yamaguchi T; Ishiwata S; Shindo H; Hishinuma T; Nozaki S; Nose M
    Clin Exp Immunol; 1997 Nov; 110(2):265-9. PubMed ID: 9367411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.